Can we predict dangerous side effects of cancer immunotherapy?

NCT ID NCT07357636

Recruiting now Knowledge-focused Sponsor: Shantou University Medical College Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 940 adult cancer patients starting immunotherapy to understand why some develop immune-related side effects, especially those affecting the brain and nerves. Researchers will collect blood samples and health data over time to find early warning signs. The goal is to better predict and manage these side effects, making immunotherapy safer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to predict and manage immune-related side effects from cancer immunotherapy, improving patient safety and quality of life.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly benefit participants. It may not find clear biomarkers, and results may take years to impact clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE-RELATED ADVERSE EVENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm toxic encephalopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

Affiliated Cancer Hospital of Shantou University Medical College
RECRUITING

Shantou, China
First Affiliated Hospital of Fujian Medical University
RECRUITING

Fuzhou, Fujian, 430074, China
Hainan Hospital of Chinese PLA General Hospital
RECRUITING

Sanya, China
Sun Yat-sen University Cancer Center
RECRUITING

Guangzhou, China
The First Affiliated Hospital of Zhengzhou University
RECRUITING

Zhengzhou, China
the First Affiliated Hospital of Shantou University Medical College
RECRUITING

Shantou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.